BioCryst Pharmaceuticals ... (BCRX)
6.84
-0.49 (-6.68%)
At close: Apr 04, 2025, 3:59 PM
6.82
-0.29%
After-hours: Apr 04, 2025, 05:49 PM EDT
BioCryst Pharmaceuticals Revenue
BioCryst Pharmaceuticals reported an annual revenue of $450.71M, reflecting a 36% growth. For the quarter ending December 31, 2024, BioCryst Pharmaceuticals generated $131.53M in revenue.
Revenue (ttm)
$450.71M
Revenue Growth
36%
Price / Sales Ratio
3.45
Revenue / Employee
$777.09K
Employees
580
Market Cap
1.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 450.71M | +36.00% |
Dec 31, 2023 | 331.41M | +22.37% |
Dec 31, 2022 | 270.83M | +72.31% |
Dec 31, 2021 | 157.17M | +782.38% |
Dec 31, 2020 | 17.81M | n/a |